You can buy or sell OCUL and other stocks, options, and ETFs commission-free!
Ocular Therapeutix, Inc. Common Stock, also called Ocular Therapeutix, is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA. The listed name for OCUL is Ocular Therapeutix, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, After Hours